Conditioning Regimen in Elderly AML Patients Receiving Haplo-HSCT.

NANot yet recruitingINTERVENTIONAL
Enrollment

307

Participants

Timeline

Start Date

May 20, 2025

Primary Completion Date

October 31, 2027

Study Completion Date

October 31, 2027

Conditions
AMLElderly
Interventions
PROCEDURE

Bu/Flu/Cy/ATG

The Bu/Flu/Cy/ATG conditioning regimen consists of the following components: Ara-C (2 g/m²/day, injected i.v.) on days-10 and-9; Bu (0.8 mg/kg, q6h, injected i.v.) on days -8 to -6; Flu (30 mg/m²/day, injected i.v.) from day-6 to day-2; Cy (1.0 g/m²/day, injected i.v.) on days-5 and-4; and ATG (2.5 mg/kg/day) on days-5 to -2.

PROCEDURE

Bu/Cy/ATG

The Bu/Cy/ATG conditioning regimen consists of the following components: Ara-C (4 g/m²/day, injected i.v.) on day-9; Bu (0.8 mg/kg, q6h, injected i.v.) on days -8 to -6; Cy (1.8 g/m²/day, injected i.v.) on days-5 and-4; and ATG (2.5 mg/kg/day) on days-5 to -2.

Trial Locations (1)

Unknown

Peking University People's Hospital, Beijing

All Listed Sponsors
lead

Peking University People's Hospital

OTHER

NCT06946602 - Conditioning Regimen in Elderly AML Patients Receiving Haplo-HSCT. | Biotech Hunter | Biotech Hunter